Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

43.29
Delayed Data
As of May 02
 +0.38 / +0.89%
Today’s Change
36.71
Today|||52-Week Range
46.10
+8.82%
Year-to-Date

Today’s Trading

Previous close42.91
Today’s open43.08
Day’s range43.00 - 43.32
Volume2,559,309
Average volume (3 months)3,707,080
Market cap$104.5B
Dividend yield5.40%
Data as of 05/02/2016

Growth & Valuation

Earnings growth (last year)+181.82%
Earnings growth (this year)+14.18%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)-3.66%
P/E ratio172.3
Price/Sales2.70
Price/Book13.78

Competitors

 Today’s
change
Today’s
% change
SNYSanofi+0.36+0.88%
NVONovo Nordisk+0.06+0.11%
ABBVAbbVie+0.44+0.72%
BMYBristol-Myers Squibb-0.22-0.30%
Data as of 05/02/2016

Financials

Next reporting dateJuly 20, 2016
EPS forecast (this quarter)$0.57
Annual revenue (last year)$36.5B
Annual profit (last year)$12.8B
Net profit margin35.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Andrew Philip Witty
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts

Partner Offers

Search for Jobs